SLC17A7 and Alzheimer disease: The research team led by Ma et al. (2022) found that the expression of glutamate transporters in the cerebral cortex of AD patients is decreased, and the decrease in vesicular glutamate transporter 1 (VGLUT1) is more pronounced.